UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Randomized, Double-Blind, Placebo-Controlled Study of Encenicline, an α7 Nicotinic Acetylcholine Receptor Agonist, as a Treatment for Cognitive Impairment in Schizophrenia

Neuropsychopharmacology (New York, N.Y.), 2015-12, Vol.40 (13), p.3053-3060

2015

Volltextzugriff (PDF)

Relationships among neurocognition, symptoms and functioning in patients with schizophrenia: a path-analytic approach for associations at baseline and following 24 weeks of antipsychotic drug therapy

BMC psychiatry, 2009-07, Vol.9 (1), p.44-44, Article 44

2009

Volltextzugriff (PDF)

A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive Disorder

Neuropsychopharmacology (New York, N.Y.), 2015-07, Vol.40 (8), p.2025-2037

2015

Volltextzugriff (PDF)

Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis

European journal of human genetics : EJHG, 2009-07, Vol.17 (7), p.946-957

2009

Volltextzugriff (PDF)

Digital Intervention for Cognitive Deficits in Major Depression: A Randomized Controlled Trial to Assess Efficacy and Safety in Adults

The American journal of psychiatry, 2022-07, Vol.179 (7), p.482-489

2022

Volltextzugriff (PDF)

Neuropsychological Impairments in Schizophrenia and Psychotic Bipolar Disorder: Findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) Study

The American journal of psychiatry, 2013-11, Vol.170 (11), p.1275-1284

2013

Volltextzugriff (PDF)

Technology, society, and mental illness: challenges and opportunities for assessment and treatment

Innovations in clinical neuroscience, 2012-11, Vol.9 (11-12), p.47-50

2012

Volltextzugriff (PDF)

Neuropsychological Decline in Schizophrenia From the Premorbid to the Postonset Period: Evidence From a Population-Representative Longitudinal Study

The American journal of psychiatry, 2014-01, Vol.171 (1), p.91-101

2014

Volltextzugriff (PDF)

Why are there no approved treatments for cognitive impairment in schizophrenia?

World psychiatry, 2019-06, Vol.18 (2), p.167-168

Keefe, Richard S.E.

2019

Volltextzugriff (PDF)

The MATRICS Consensus Cognitive Battery, Part 2: Co-Norming and Standardization

The American journal of psychiatry, 2008-02, Vol.165 (2), p.214-220

2008

Volltextzugriff (PDF)

The MATRICS Consensus Cognitive Battery, Part 1: Test Selection, Reliability, and Validity

The American journal of psychiatry, 2008-02, Vol.165 (2), p.203-213

2008

Volltextzugriff (PDF)

Cognitive Effects of Atypical Antipsychotic Medications in Patients With Alzheimer's Disease: Outcomes From CATIE-AD

The American journal of psychiatry, 2011-08, Vol.168 (8), p.831-839

2011

Volltextzugriff (PDF)

Microvascular Abnormality in Schizophrenia as Shown by Retinal Imaging

The American journal of psychiatry, 2013-12, Vol.170 (12), p.1451-1459

2013

Volltextzugriff (PDF)

Randomized, Double-Blind, Placebo-Controlled Study of Encenicline, an alpha 7 Nicotinic Acetylcholine Receptor Agonist, as a Treatment for Cognitive Impairment in Schizophrenia

Neuropsychopharmacology (New York, N.Y.), 2015-12, Vol.40 (13), p.3053-3060

2015

Volltextzugriff (PDF)

A Randomized, Placebo-Controlled Study Investigating the Nicotinic α7 Agonist, RG3487, for Cognitive Deficits in Schizophrenia

Neuropsychopharmacology (New York, N.Y.), 2014-06, Vol.39 (7), p.1568-1577

2014

Volltextzugriff (PDF)

Location-based differences in cognition and functional capacity: Consistent levels of impairment in participants with schizophrenia compared to healthy controls

Psychiatry research, 2024-10, Vol.340, p.116121, Article 116121

2024

Volltextzugriff (PDF)

Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia

The New England journal of medicine, 2005-09, Vol.353 (12), p.1209-1223

2005

Volltextzugriff (PDF)

Effectiveness of Clozapine Versus Olanzapine, Quetiapine, and Risperidone in Patients With Chronic Schizophrenia Who Did Not Respond to Prior Atypical Antipsychotic Treatment

The American journal of psychiatry, 2006-04, Vol.163 (4), p.600-610

2006

Volltextzugriff (PDF)

The Schizophrenia Cognition Rating Scale: An Interview-Based Assessment and Its Relationship to Cognition, Real-World Functioning, and Functional Capacity

The American journal of psychiatry, 2006-03, Vol.163 (3), p.426-432

2006

Volltextzugriff (PDF)

A Randomized, Placebo-Controlled Study Investigating the Nicotinic [alpha]7 Agonist, RG3487, for Cognitive Deficits in Schizophrenia

Neuropsychopharmacology (New York, N.Y.), 2014-06, Vol.39 (7), p.1568

2014

Volltextzugriff (PDF)

Lisdexamfetamine Dimesylate Augmentation in Adults With Persistent Executive Dysfunction After Partial or Full Remission of Major Depressive Disorder

Neuropsychopharmacology (New York, N.Y.), 2014-05, Vol.39 (6), p.1388-1398

2014

Volltextzugriff (PDF)

Virtual reality assessment of functional capacity in people with Schizophrenia: Associations with reduced emotional experience and prediction of functional outcomes

Psychiatry research, 2019-07, Vol.277, p.58-63

2019

Volltextzugriff (PDF)

Functional Co-Primary Measures for Clinical Trials in Schizophrenia: Results From the MATRICS Psychometric and Standardization Study

The American journal of psychiatry, 2008-02, Vol.165 (2), p.221-228

2008

Volltextzugriff (PDF)

Effects of Olanzapine, Quetiapine, and Risperidone on Neurocognitive Function in Early Psychosis: A Randomized, Double-Blind 52-Week Comparison

The American journal of psychiatry, 2007-07, Vol.164 (7), p.1061-1071

2007

Volltextzugriff (PDF)

The Brief Assessment of Cognition In Affective Disorders (BAC-A):Performance of patients with bipolar depression and healthy controls

Journal of affective disorders, 2014-09, Vol.166, p.86-92

2014

Volltextzugriff (PDF)

1 – 25 von 79

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(78)
Mit Volltextzugriff
(76)

Publikationsform

Artikel
(79)

Sprache

Englisch
(79)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(50)
Life Sciences & Biomedicine
(46)
Schizophrenia
(46)
Science & Technology
(46)
Psychiatry
(42)
Female
(39)
Male
(39)
Adult
(38)
Schizophrenic Psychology
(30)
Biological And Medical Sciences
(29)
Medical Sciences
(29)
Psychology. Psychoanalysis. Psychiatry
(28)
Psychopathology. Psychiatry
(28)
Schizophrenia - Drug Therapy
(24)
Adult And Adolescent Clinical Studies
(23)
Antipsychotic Agents - Therapeutic Use
(21)
Neuropsychological Tests
(21)
Psychoses
(21)
Cognition & Reasoning
(19)
Middle Aged
(19)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Randomized, Double-Blind, Placebo-Controlled Study of Encenicline, an α7 Nicotinic Acetylcholine Receptor Agonist, as a Treatment for Cognitive Impairment in Schizophrenia

Relationships among neurocognition, symptoms and functioning in patients with schizophrenia: a path-analytic approach for associations at baseline and following 24 weeks of antipsychotic drug therapy

A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive Disorder

Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis

Digital Intervention for Cognitive Deficits in Major Depression: A Randomized Controlled Trial to Assess Efficacy and Safety in Adults

Neuropsychological Impairments in Schizophrenia and Psychotic Bipolar Disorder: Findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) Study

Technology, society, and mental illness: challenges and opportunities for assessment and treatment

Neuropsychological Decline in Schizophrenia From the Premorbid to the Postonset Period: Evidence From a Population-Representative Longitudinal Study

Why are there no approved treatments for cognitive impairment in schizophrenia?

The MATRICS Consensus Cognitive Battery, Part 2: Co-Norming and Standardization

The MATRICS Consensus Cognitive Battery, Part 1: Test Selection, Reliability, and Validity

Cognitive Effects of Atypical Antipsychotic Medications in Patients With Alzheimer's Disease: Outcomes From CATIE-AD

Microvascular Abnormality in Schizophrenia as Shown by Retinal Imaging

Randomized, Double-Blind, Placebo-Controlled Study of Encenicline, an alpha 7 Nicotinic Acetylcholine Receptor Agonist, as a Treatment for Cognitive Impairment in Schizophrenia

A Randomized, Placebo-Controlled Study Investigating the Nicotinic α7 Agonist, RG3487, for Cognitive Deficits in Schizophrenia

Location-based differences in cognition and functional capacity: Consistent levels of impairment in participants with schizophrenia compared to healthy controls

Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia

Effectiveness of Clozapine Versus Olanzapine, Quetiapine, and Risperidone in Patients With Chronic Schizophrenia Who Did Not Respond to Prior Atypical Antipsychotic Treatment

The Schizophrenia Cognition Rating Scale: An Interview-Based Assessment and Its Relationship to Cognition, Real-World Functioning, and Functional Capacity

A Randomized, Placebo-Controlled Study Investigating the Nicotinic [alpha]7 Agonist, RG3487, for Cognitive Deficits in Schizophrenia

Lisdexamfetamine Dimesylate Augmentation in Adults With Persistent Executive Dysfunction After Partial or Full Remission of Major Depressive Disorder

Virtual reality assessment of functional capacity in people with Schizophrenia: Associations with reduced emotional experience and prediction of functional outcomes

Functional Co-Primary Measures for Clinical Trials in Schizophrenia: Results From the MATRICS Psychometric and Standardization Study

Effects of Olanzapine, Quetiapine, and Risperidone on Neurocognitive Function in Early Psychosis: A Randomized, Double-Blind 52-Week Comparison

The Brief Assessment of Cognition In Affective Disorders (BAC-A):Performance of patients with bipolar depression and healthy controls

Suchergebnisse filtern